Outcomes from treating tuberculosis with rifampicin or rifabutin in HIV-infected persons also receiving antiretroviral therapy.
| Autor: | Rawson TM; Imperial College London, London, United Kingdom †Research Department of Infection and Population Health, University College London, London, United Kingdom ‡St. Stephen's Centre, Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom §TB Service, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Brima N, Almajid F, Pozniak AL, Janmohamed A, Mandalia S, Basnayake S, Kellgren L, Copas AJ, Miller RF |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2015 Apr 15; Vol. 68 (5), pp. e84-7. |
| DOI: | 10.1097/QAI.0000000000000515 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|